The other C-terminal modifications include additions of Human serum albumin (3 entries), cholesterol (2 entries), PEG (24 entries), XTEN (4 entries), Fc-region (14 entries), etc
Kroenke K, Spitzer RL, Williams JB
Limitations include relatively short treatment periods (6 weeks per arm), potential carryover effects despite washout, modest sample size limiting power for subgroup analyses and exclusion of newer agents (e.g., tapentadol) and long-term safety outcomes, which may restrict applicability to broader clinical practice
Structural trait markers of bipolar disorder: disruption of white matter integrity and localized gray matter abnormalities in anterior fronto-limbic regions
Treatment options for weight regain or Insufcient weight loss after sleeve gastrectomy: a systematic review and Meta-analysis
In the future, more efficient and stable new carrier systems can be developed, such as nanoparticle carriers based on biodegradable materials or smart-responsive carriers, to further enhance the bioavailability of food-derived compounds
